Skip to main content

Clinical Research Organization Services Market by 2018-2033

Clinical research organization services are the services provided by the clinical research organizations (CROs) to the pharmaceutical, biotechnology, and medical device companies. Clinical research organization services include clinical trial management, clinical data management, biostatistics, regulatory affairs, and other services. The global clinical research organization services market is expected to reach USD 59.2 billion by 2033 from USD 33.2 billion in 2018, at a CAGR of 6.7%.

Clinical Research Organization Services Market by 2018-2033

The growth of the clinical research organization services market is mainly driven by the increasing number of clinical trials, rising demand for outsourcing of clinical trials, and increasing focus on the development of biologics and biosimilars. However, the high cost of clinical trials and stringent regulatory requirements are expected to restrain the growth of this market during the forecast period.

The clinical trial management segment is expected to account for the largest share of the clinical research organization services market in 2018.

On the basis of service, the clinical research organization services market is segmented into clinical trial management, clinical data management, biostatistics, regulatory affairs, and other services. The clinical trial management segment is expected to account for the largest share of the market in 2018. The large share of this segment can be attributed to the increasing number of clinical trials and the rising demand for outsourcing of clinical trials.

The biopharmaceutical segment is expected to account for the largest share of the clinical research organization services market in 2018.
On the basis of end user, the clinical research organization services market is segmented into biopharmaceutical companies, medical device companies, and other end users. The bio-pharmaceutical segment is expected to account for the largest share of the market in 2018. The large share of this segment can be attributed to the increasing number of clinical trials and the rising demand for outsourcing of clinical trials.

North America is expected to account for the largest share of the clinical research organization services market in 2018.

North America is expected to account for the largest share of the clinical research organization services market in 2018. The large share of this region can be attributed to the increasing number of clinical trials, rising demand for outsourcing of clinical trials, and increasing focus on the development of biologics and biosimilars.

The major players in the clinical research organization services market are Vial CRO, Parexel International Corporation (US), IQVIA (US), Covance Inc. (US), ICON plc (Ireland), PRA Health Sciences, Inc. (US), Syneos Health (US), Charles River Laboratories International, Inc. (US), inVentiv Health, Inc. (US), Medpace Holdings, Inc. (US), and Pharmaceutical Product Development, LLC (US).

Labels:
Location: United States

Comments

Post a Comment

Popular posts from this blog

Preclinical Contract Research Organization (CRO) Market by Manufacture, Sales, Revenue, Forecast by Regions 2023-2029

The Preclinical Contract Research Organization (CRO) Market report provides a comprehensive overview of the market, including market dynamics, segmentation, and regional analysis. The Preclinical Contract Research Organization (CRO) Market report report also provides an overview of the competitive landscape and the key strategies adopted by market players to gain a competitive edge in the market.  The Preclinical Contract Research Organization - CRO`s Market report also provides an overview of the competitive landscape and the key strategies adopted by market players to gain a competitive edge in the market. The report provides an in-depth analysis of the Preclinical Contract Research Organization (CRO) market, including market size, growth drivers, market trends, and competitive landscape. The report also provides an overview of the key players in the market and their strategies for gaining a competitive edge in the market. The report also provides an overview of the key trends ...
Post a Comment
Read more

Exploring Huge Demand of Oncology CRO Market 2023 - 2033

The Oncology CRO market is expected to grow significantly over the forecast period due to the increasing prevalence of cancer, rising demand for personalized medicine, and the growing need for cost-effective drug development. The increasing number of clinical trials in Oncology and the growing demand for outsourcing services are also expected to drive the growth of the market. The Oncology CRO‘s market is segmented based on type, end-user, and region. By type, the market is divided into preclinical, clinical, and post-marketing services. Preclinical services are expected to hold the largest share of the market due to the increasing demand for preclinical studies in oncology. Clinical services are expected to witness the highest growth rate due to the increasing number of clinical trials in oncology. By end-user, the market is divided into pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations. Pharmaceutical and biotechnology...
Post a Comment
Read more